AEVIS Holding SA
- WKN: 925444
- ISIN: CH0012488190
- Land: Schweiz
Nachricht vom 02.07.2012 | 17:30
AEVIS Holding SA: Extraordinary General Meeting : All propositions approved
AEVIS Holding SA / Key word(s): AGM/EGM 02.07.2012 17:30 Release of an ad hoc announcement pursuant to Art. 53 KR --------------------------------------------------------------------------- SHP 100% subsidiary of AEVIS Christian Wenger has been appointed Chairman of the Board of Directors Fribourg, 2 July 2012 - All agenda items have been approved by the shareholders at the Extraordinary General Meeting of AEVIS Holding SA which was held today in Fribourg. The share capital of the company will be increased by CHF 28'000'0000 with a contribution in kind of all outstanding shares of Swiss Healthcare Properties AG and the number of outstanding shares of the company will rise to 12'678'479 (7'078'479). Christian Wenger has been elected and will become Chairman of the Board of Directors, Raymond Loretan, Chairman of Genolier Swiss Medical Network SA, will become Vice-Chairman while Cédric A. George, Antoine Kohler, Michel Reybier and Antoine Hubert, Managing Director, will be members of the Board. AEVIS Holding SA will develop its two segments dissimilar, depending on opportunities. The share capital of the company will be increased with the issue of 5'600'000 new registered shares with a nominal value of CHF 5 per share. The new shares will be issued in exchange for a contribution in kind of all outstanding shares of Swiss Healthcare Properties AG. The new shares will be issued on 3 July 2012 and will be listed on 4 July 2012. After the transaction, the share capital of AEVIS Holding SA will surge to CHF 63'392'395 with 12'678'479 shares outstanding. AEVIS Holding SA will be structured in way to secure funds necessary to finance the next growth steps by way of capital increases or the issue of bonds. The balance sheet structure and cash flows will be improved with the integration of the real estate portfolio. This acquisition will increase the operational profitability of the company and lead to an EBITDA in the excess of CHF 50 million in 2012. The Board of Directors of AEVIS Holding SA is now composed of Christian Wenger, Chairman, Raymond Loretan, Vice-Chairman, Antoine Hubert, Managing Director, Michel Reybier, Antoine Kohler and Dr. Cédric A. George. The Board of Directors of Genolier Swiss Medical Network remains unchanged. Raymond Loretan, Chairman, Philippe Glasson, Vice-Chairman, Antoine Hubert, Managing Director, Michel Reybier, Fulvio Pelli, Christian Le Dorze, Cédric A. George and Antoine Kohler continue to serve in their functions. Genolier Swiss Medical Network is the second biggest group of private clinics in Switzerland and the only market player with presence in all three linguistic areas of Switzerland. The growth strategy is reflected in a nationwide portfolio of clinics with strong local reputation. GSMN consists of 10 private clinics in Switzerland with nearly 1'000 affiliated physicians and 2'000 employees. Swiss Healthcare Properties AG is the only real estate company in Switzerland focusing on real estate and infrastructure in the health care sector only. SHP owns 13 Swiss health care properties covering an area of more than 73'000m2 and representing a total value of CHF 355 million. SHP will acquire further properties in the near future reflecting the development of GSMN. The Board of Directors of Swiss Healthcare Properties AG is composed of Antoine Hubert, Chairman, Michel Reybier, Vice-Chairman, Gilles Frachon and Olivier Bourgeois. The Senior Management of AEVIS Holding SA will be composed of Antoine Hubert, Managing Director, Beat Röthlisberger, CEO of GSMN, Gilles Frachon, CFO and Séverine Van der Schueren, CAO. For further information: Media and Investor Relations AEVIS Holding SA : c/o Dynamics Group, Zurich Edwin van der Geest, email@example.com, +41 (0) 43 268 32 35 or +41 (0) 79 330 55 22 Philippe R. Blangey, firstname.lastname@example.org, +41 (0) 43 268 32 35 or +41 (0) 79 785 46 32 About AEVIS Holding SA AEVIS Holding SA invests in the healthcare sector, in life sciences and services to people. The participations of AEVIS are the 2nd group of private clinics in Switzerland 'Genolier Swiss Medical Network', Swiss Healthcare Properties AG, a company specialised in healthcare real estate, Nescens SA, a brand dedicated to Better Aging and Les Hauts de Genolier SA, a company managing medical residences. AEVIS plans to gradually develop new operational or infrastructural businesses, amongst others in the field of ambulatory centres, radiology or dental medicine. AEVIS Holding SA is listed on the Domestic Standard of the SIX Swiss Exchange (AEVS). 02.07.2012 News transmitted by EquityStory AG. The issuer is responsible for the contents of the release. EquityStory publishes regulatory releases, media releases on the capital market and press releases. The EquityStory Group distributes authentic and real-time financial news for over 1'300 listed companies. The Swiss news archive can be found at www.equitystory.ch/news ---------------------------------------------------------------------------
AEVIS Holding SA - Assemblée Générale Ordinair ...
AEVIS Holding SA: Chiffre d'Affaires Q1 en hau ...
AEVIS Holding SA: Publication of the Annual Re ...
AEVIS Holding SA: Swiss Healthcare Properties ...
AEVIS Holding SA - GSMN SA: Finalisation de l' ...
Anleihe im Fokus
Die DF-Anleihe 7,875%
Mit der DF Forfait AG vom wachsenden Welthandel profitieren
- Zeichnungsfrist: 21.05. bis 24.05.2013
- Laufzeit: 7 Jahre
- Kupon: 7,875% p.a.
- Volumen: bis zu 30 Mio. Euro
- ISIN: DE000A1R1CC4
Anleihe im Fokus
7,75% p.a. - Rendite aus Familienhand
– Zeichnungsstart: 23. Mai – Börse Frankfurt
– Zeichnung ab 1.000 Euro
– Laufzeit 5 Jahre
– WKN: A1TNA7
– 100% Rückzahlungskurs
HELMA Eigenheimbau AG: Kaufen
Die HELMA Eigenheimbau AG präsentierte für das Geschäftsjahr 2012 Rekordwerte. Auf Basis unseres DCF-Modells haben wir einen fairen Wert je Aktie von 22,75 € ermittelt. Ausgehend vom erwarteten 2013er-EPS von 1,64 € entspricht dies einem KGV von 8,4. Das Kurspotenzial beläuft sich auf nahezu 65%.
Der AKTIONÄR News
20. Mai 07:50 Hochtief: Tochter verleiht Flügel
20. Mai 07:30 US-Dollar/Yen: 100-Yen-Marke ist Geschichte
News im Fokus
Fresenius Medical Care AG & Co. KGaA: Bekanntmachung nach Art. 4 Abs. 2 der Verordnung (EG) Nr. 2273/2003
17. Mai 2013, 17:35
Analysts' conference call on 1Q 2013
15. Mai 2013
Original-Research: Plan Optik AG (von GBC AG): Kaufen Plan Optik AG
17. Mai 2013